+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Blood Screening and Typing: Global Markets

  • PDF Icon

    Report

  • 168 Pages
  • March 2019
  • Region: Global
  • BCC Research
  • ID: 4760630
UP TO OFF until Aug 31st 2033

Report Scope:

This report focuses on the screening and analysis of donor blood and patient blood. It covers the current market dynamics and various forces that are impacting the market. Two markets are analyzed: blood screening and blood typing. By technology, the blood screening market is segmented into serological technologies Enzyme linked immunosorbent assay (ELISA) and chemiluminescence immunoassay (CLIA), agglutination tests such as gel card agglutination, microplate-based agglutination, and lateral flow tests), nucleic acid amplification technologies (PCR-based and non-PCR based), microbiology techniques (blood culture and antimicrobial susceptibility tests) and niche technologies such as microarray, DNA sequencing.

By blood supply, the market is segmented into patient blood and donor blood. Patient blood supply analysis covers the qualitative detection of infectious diseases such as sexually transmitted diseases and blood-borne infections like sepsis, and blood grouping and typing analysis tests. Donor blood testing involves analysis of donor blood units, including infectious disease screening and blood grouping tests.

By end-user, the market is segmented into hospitals, standalone blood banks, and reference laboratories. By region, the blood screening and typing market is segmented into North America, Europe, the Asia-Pacific region and Rest of the World (ROW). ROW includes South America, the Middle East, and Africa. This report also covers the competitive landscape, detailing the companies engaged in offering products for blood screening and typing. Detailed profiles of the top leading companies are also included.

The Report Includes:


  • 31 data tables and 34 additional tables
  • An overview of recent key developments in the global blood screening and typing market and a look ahead at the next five years
  • Analyses of global market trends with data from 2017 and 2018, and projections of compound annual growth rates (CAGRs) through 2023
  • Quantitative data covering the overall market by analyzers, kits, reagents and consumables, immunoassay techniques, technology types, microbiology techniques, blood types, and consumer groups
  • Regional dynamics of the blood screening market covering North America, Europe, Asia-Pacific and Rest of the world including countries of South America, the Middle East, and Africa
  • Study of impact analysis and discussion of technological, regulatory, and economic trends that are affecting the global blood screening market
  • Company profiles of the leading market players, including Abbott Laboratories, Becton, Dickinson and Co., Bio-Rad Laboratories, Danaher Corp. and Thermo Fisher Scientific, Inc.

Table of Contents

Chapter 1 Introduction
  • Scope of Report
  • Inclusions
  • Exclusions
  • Information Sources
  • Methodology
  • Market Estimation and Forecast
  • Geographic Breakdown
  • Analyst's Credentials
  • Custom Research
  • Related Reports



Chapter 2 Summary and Highlights
  • Key Findings



Chapter 3 Blood Industry Landscape
  • Overview of Blood
  • Composition of Blood
  • Functions of Blood
  • Classification of Blood Groups
  • ABO Blood Group
  • H Antigen
  • Rhesus System
  • MNS System
  • Lutheran System
  • Kell System
  • Duffy Antigen System
  • Kidd Antigen
  • Blood Collection and Transfusion
  • Types of Blood Establishments and Blood Facilities
  • Methods for Collecting Blood from a Donor
  • Plasma Collection
  • Blood Transfusions
  • Types of Transfusions
  • Complications Associated with Blood Transfusions
  • Transfusion Transmissible Infections
  • National Healthcare Safety Network-Biovigilance Component Hemovigilance Module Surveillance
  • Diseases Contracted from Blood Transfusions and Related Identification Testing
  • Human Immunodeficiency Virus (HIV)
  • Epidemiology of Sexually Transmittable Diseases
  • Blood Screening and Evaluation
  • Efforts to Create a Virus-Free Blood Supply
  • Negative Reactions from Blood Transfusions
  • Blood/Plasma Component Risks
  • Blood Management Issues
  • Availability Issues
  • Bloodless Surgery
  • Safety Issues: Risk Management
  • Blood-Transfusion Fatalities



Chapter 4 Market Definition and Dynamics
  • Definition
  • Blood Screening
  • Blood Grouping and Typing
  • Market Drivers
  • Increasing Incidence of Chronic Diseases and Infections
  • Demand for Blood and Blood Transfusion Services
  • Favorable Safety Regulatory Policies for Blood Products
  • Increase in Automation
  • Market Restraints
  • Government Policies
  • Price Pressure on Manufacturers
  • Shortage of Skilled Laboratory Technicians
  • Emerging Trends and Opportunities
  • Multiplexing for Blood Screening
  • Development of Novel Technologies: DNA Sequencing and Microarray Technologies



Chapter 5 Market Segment Analysis
  • Segment Analysis, by Technology
  • Immunoassay
  • Market Size and Forecast
  • Nucleic Acid Amplification Technology
  • Polymerase Chain Reaction Amplification
  • Other Nucleic Acid Amplification Technologies
  • Market Size and Forecast
  • Immunohematology (Blood Typing) Techniques
  • Manual Typing Methods
  • Automated Blood Typing
  • Market Size and Forecast
  • Microbial Techniques
  • Blood Stream Infections
  • Blood Cell Culture and Antimicrobial Susceptibility Testing
  • BioMerieux’s VITEK 2 System
  • Becton, Dickinson and Company’s BD Phoenix Identification and Susceptibility Testing System
  • Market Size and Forecast
  • Niche Emerging Technologies
  • DNA Sequencing
  • Microarray
  • Market Size and Forecast
  • Segment Analysis, by End User
  • Reference Laboratories
  • Standalone Blood Banks
  • Hospitals
  • Segment Analysis, by Blood Type
  • Donor Blood
  • Patient Blood



Chapter 6 Market Breakdown by Region
  • Introduction and Regional Markets
  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of the World (RoW)
  • South America
  • The Middle East and Africa



Chapter 7 Regulatory and Reimbursement Landscape
  • Regulations in the United States
  • Statutory Authority of the FDA
  • Major Regulations and Policy Matters Concerning the U.S. Blood Supply
  • Implementation of Regulations
  • Guidance for Industry Recognition and Use of a Standard for the Uniform Labeling of Blood and Blood Components
  • Other Organizations Involved in Blood Regulation
  • Voluntary Regulation, by Professional and Trade Associations
  • Reimbursement Landscape in the United States
  • Preventive Care Services
  • Regulations in Europe
  • The International Society for Blood Transfusion: ISBT 128
  • Regulations in the Asia-Pacific
  • Regulations in Central and South America
  • Regulations in the Middle East and Africa



Chapter 8 Market Share Analysis and Recent Industry Developments
  • Market Share Analysis
  • Market Share Analysis in the Nucleic Acid Test Segment
  • Market Share Analysis in the Immunoassay Tests Segment
  • Market Share Analysis in the Immunohematology Segment
  • Market Share Analysis in the Microbiology Segment
  • Recent Industry Developments



Chapter 9 Company Profiles
  • Abbott Laboratories
  • Agena Bioscience
  • Axo Science
  • Bag Health Care Gmbh
  • Becton, Dickinson and Co.
  • Bio-Rad Laboratories
  • Biomérieux Sa
  • Danaher Corp.
  • Day Medical Sa
  • Diagast
  • F. Hoffmann-La Roche Ltd.
  • Grifols S.A.
  • Immucor
  • Novacyt Group
  • Ortho Clinical Diagnostics
  • Quotient
  • Siemens Healthcare Gmbh
  • Thermo Fisher Scientific, Inc.



List of Tables
Summary Table: Global Market for Blood Screening and Typing, by Technology, Through 2023
Table 1: Composition of Blood Plasma
Table 2: Types of Cellular Elements Present in Blood
Table 3: Diseases That can be Treated with Plasmapheresis
Table 4: Red Blood Cells Compatibility
Table 5: Compatibility of ABO and RH Systems
Table 6: Selected Uses of Fresh Frozen Plasma
Table 7: Usage and Therapeutic Effect of Cryoprecipitate
Table 8: U.S. Major Diseases Contracted from Blood Transfusions
Table 9: Chlamydia Incidence in Selected Countries, 2012-2017
Table 10: Global HSV-1 Prevalence, Aged 0-49 years, 2012
Table 11: Gonorrhea Epidemiology in Selected Countries, 2012-2017
Table 12: HIV Incidence, by Country, 2005-2016
Table 13: Syphilis Incidence, by Country, 2013-2016
Table 14: Factors to Reduce Risks of Transfusion-Associated Diseases
Table 15: Transfusion-Related Fatalities, by Complication, 2008-2013
Table 16: Fatalities Not Related to Transfusion or Transfusion Not Ruled Out, FY2008-FY2013
Table 17: Post-Donation “Not Ruled Out” Fatality Reports, by Donated Product, FY2008-FY2013
Table 18: Global Market for Blood Screening and Typing, by Technology, Through 2023
Table 19: Global Market for Immunoassay Tests, by Region, Through 2023
Table 20: Selected PCR Screening Tests, by Type
Table 21: Global Market for Nucleic Acid Amplification Technology, by Region, Through 2023
Table 22: Global Market for Immunohematology Devices, by Region, Through 2023
Table 23: Global Market for Microbial Techniques, by Region, Through 2023
Table 24: Global Market for Niche Technologies, by Region, Through 2023
Table 25: Global Market for Blood Screening and Typing, by End User, Through 2023
Table 26: Global Market for Blood Screening and Typing in Reference Laboratories, by Region, Through 2023
Table 27: Global Market for Blood Screening and Typing in Standalone Blood Banks, by Region, Through 2023
Table 28: Global Market for Blood Screening and Typing in Hospitals, by Region, Through 2023
Table 29: Global Market for Blood Screening and Typing, by Type, Through 2023
Table 30: Global Market for Donor Blood Testing Equipment, by Region, Through 2023
Table 31: Global Market for Patient Blood Testing Equipment, by Region, Through 2023
Table 32: Global Market for Blood Screening and Typing, by Region, Through 2023
Table 33: North American Market for Blood Screening and Typing, by Country, Through 2023
Table 34: European Market for Blood Screening and Typing, by Country, Through 2023
Table 35: Asia-Pacific Market for Blood Screening and Typing, by Country, Through 2023
Table 36: Donation and Distribution (JRCS 2015)
Table 37: RoW Market for Blood Screening and Typing, by Country, Through 2023
Table 38: Federal Organizations Responsible for U.S. Blood Safety
Table 39: FDA Authority in Regulating Blood Banking and Blood Products
Table 40: Major Areas of Concern for Inspecting Blood Facilities
Table 41: Classification of In Vitro Diagnostic Devices Under the European IVDR
Table 42: Leading Companies, by Technology Segment
Table 43: Recent Industry Developments, February 2016-December 2018
Table 44: Abbott Laboratories: Company Net Revenue, 2015-2017
Table 45: Abbott Laboratories: Products
Table 46: Becton, Dickinson and Co.: Company Net Revenue, 2015-2017
Table 47: Becton, Dickinson and Co.: Products and Services
Table 48: Bio-Rad Laboratories: Company Net Revenue, 2015-2017
Table 49: Bio-Rad Laboratories: Products and Services
Table 50: Biomérieux SA: Company Net Revenue, 2015-2017
Table 51: BioMérieux SA: Products and Services
Table 52: Danaher Corp.: Company Net Revenue, 2015-2017
Table 53: Danaher Corp.: Products and Services
Table 54: F. Hofmann-La Roche Ltd.: Company Net Revenue, 2015-2017
Table 55: F. Hofmann-La Roche Ltd.: Products and Services
Table 56: Grifols S.A: Company Net Revenue, 2015-2017
Table 57: Grifols S.A: Products and Services
Table 58: Immucor: Company Net Revenue, 2014-2016
Table 59: Immucor: Products and Services
Table 60: Ortho Clinical: Diagnostics Products and Services
Table 61: Siemens Healthineers GmbH: Company Net Revenue, 2015-2017
Table 62: Siemens Healthineers GmbH: Products and Services
Table 63: Thermo Fisher Scientific, Inc.: Company Net Revenue, 2015-2017
Table 64: Thermo Fischer Scientific, Inc.: Products and Services
List of Figures
Summary Figure A: Global Market for Blood Screening and Typing, by Technology, 2017-2023
Summary Figure B: Global Market Share for Blood Screening and Typing, by Technology, 2017
Figure 1: HIV Infected Population, by Region, 2016
Figure 2: Projected Increase in Workforce Needs in the U.S., 2016-2026
Figure 3: Global Market for Blood Screening and Typing, by Technology, 2017-2023
Figure 4: Global Market Share for Blood Screening and Typing, by Technology, 2017
Figure 5: Global Market for Immunoassay Tests, by Region, 2017-2023
Figure 6: Global Market Share for Immunoassay Tests, by Region, 2017
Figure 7: Global Market for Nucleic Acid Amplification Technology, by Region, 2017-2023
Figure 8: Global Market Share for Nucleic Acid Amplification Technology, by Region, 2017
Figure 9: Global Market for Immunohematology Devices, by Region, 2017-2023
Figure 10: Global Market Share for Immunohematology Devices, by Region, 2017
Figure 11: Global Market for Microbial Techniques, by Region, 2017-2023
Figure 12: Global Market Share for Microbial Techniques, by Region, 2017
Figure 13: Global Market for Niche Technologies, by Region, Through 2023
Figure 14: Global Market Share for Niche Technologies, by Region, 2017
Figure 15: Global Market for Blood Screening and Typing, by End User, 2017-2023
Figure 16: Global Market Share for Blood Screening and Typing, by End User, 2017
Figure 17: Global Market for Blood Screening and Typing in Reference Laboratories, by Region, 2017-2023
Figure 18: Global Market Share for Blood Screening and Typing in Reference Laboratories, by Region, 2017
Figure 19: Global Market for Blood Screening and Typing in Standalone Blood Banks, by Region, 2017-2023
Figure 20: Global Market Share for Blood Screening and Typing in Standalone Blood Banks, by Region, 2017
Figure 21: Global Market for Blood Screening and Typing in Hospitals, by Region, 2017-2023
Figure 22: Global Market Share for Blood Screening and Typing in Hospitals, by Region, 2017
Figure 23: Global Market for Blood Screening and Typing, by Type, 2017-2023
Figure 24: Global Market Share for Blood Screening and Typing, by Type, 2017
Figure 25: Global Market for Donor Blood Testing Equipment, by Region, 2017-2023
Figure 26: Global Market Share for Donor Blood Testing Equipment, by Region, 2017
Figure 27: Global Market for Patient Blood Testing Equipment, by Region, 2017-2023
Figure 28: Global Market Share for Patient Blood Testing Equipment, by Region, 2017
Figure 29: Global Market for Blood Screening and Typing, by Region, 2017-2023
Figure 30: Global Market Share for Blood Screening and Typing, by Region, 2017
Figure 31: North American Market for Blood Screening and Typing, by Country, 2017-2023
Figure 32: North American Market Share for Blood Screening and Typing, by Country, 2017
Figure 33: European Market for Blood Screening and Typing, by Country, 2017-2023
Figure 34: European Market Share for Blood Screening and Typing, by Country, 2017
Figure 35: Asia-Pacific Market for Blood Screening and Typing, by Country, 2017-2023
Figure 36: Asia-Pacific Market Share for Blood Screening and Typing, by Country, 2017
Figure 37: RoW Market for Blood Screening and Typing, by Country, 2017-2023
Figure 38: RoW Market Share for Blood Screening and Typing, by Country, 2017
Figure 39: Global Market Share Analysis of Blood Screening and Typing, by Company, 2017
Figure 40: Nucleic Acid Test, Market Share Analysis, by Company, 2017
Figure 41: Immunoassay Tests, Market Share Analysis, by Company, 2017
Figure 42: Immunohematology, Market Share Analysis, by Company, 2017
Figure 43: Microbiology, Market Share Analysis, by Company, 2017
Figure 44: Abbott Laboratories: Revenue, by Business Segment, 2015-2017
Figure 45: Abbott Laboratories: Revenue, by Country, 2015-2017
Figure 46: Abbott Laboratories: Revenue Share, by Diagnostics Segment, 2017
Figure 47: Becton, Dickinson and Co.: Revenue Share, by Business Segment, 2017
Figure 48: Becton, Dickinson and Co.: Revenue Share, by Region/Country, 2017
Figure 49: Bio-Rad Laboratories: Revenue, by Business Segment, 2015-2017
Figure 50: Bio-Rad Laboratories: Revenue, by Region/Country, 2015-2017
Figure 51: Bio-Rad Laboratories Revenue Share, by Region/Country, 2017
Figure 52: BioMérieux SA: Revenue, by Business Segment, 2015-2017
Figure 53: BioMérieux SA: Revenue, by Region, 2015-2017
Figure 54: Danaher Corp.: Revenue, by Business Segment, 2015-2017
Figure 55: Danaher Corp.: Revenue, by Region, 2015-2017
Figure 56: Danaher Corp.: Revenue Share, by Diagnostics, 2017
Figure 57: Danaher Corp.: Revenue Share, by Region, 2017
Figure 58: F. Hofmann-La Roche Ltd.: Revenue, by Business Segment, 2015-2017
Figure 59: F. Hofmann-La Roche Ltd.: Revenue, by Diagnostics Segment, 2015-2017
Figure 60: F. Hofmann-La Roche Ltd.: Revenue, by Region, 2015-2017
Figure 61: Grifols S.A: Revenue, by Business Segment, 2015-2017
Figure 62: Grifols S.A: Revenue Share, by Business Segment, 2015-2017
Figure 63: Immucor: Revenue, by Business Segment, 2014-2016
Figure 64: Immucor: Revenue, by Region/Country, 2014-2016
Figure 65: Siemens Healthineers GmbH: Revenue, by Business Segment, 2015-2017
Figure 66: Siemens Healthineers GmbH: Revenue Share, by Business Segment, 2017
Figure 67: Siemens Healthineers GmbH: Revenue Share, by Diagnostics Segment, 2017
Figure 68: Siemens Healthineers GmbH: Revenue Share, by Region, 2017
Figure 69: Thermo Fischer Scientific, Inc.: Revenue Share, by Business Unit, 2017
Figure 70: Thermo Fischer Scientific, Inc.: Revenue Share, by Country, 2017

Samples

Loading
LOADING...

Executive Summary

Growth is primarily driven by the increasing prevalence of chronic and infectious disease like sexually transmitted disease and blood infections. Increases in automation have had a profound impact on the analysis of large sample units of blood with limited errors. New technological products like sequencing and microarrays are expected to propel the growth of the market.

This report focuses on the screening and analysis of donor blood and patient blood. It covers the current market dynamics and various forces that are impacting the market. Two markets are analyzed: blood screening and blood typing. By technology, the blood screening market is segmented into serological technologies Enzyme linked immunosorbent assay (ELISA) and chemiluminescence immunoassay (CLIA), agglutination tests such as gel card agglutination, microplate-based agglutination, and lateral flow tests), nucleic acid amplification technologies (PCR-based and non-PCR based), microbiology techniques (blood culture and antimicrobial susceptibility tests) and niche technologies such as microarray, DNA sequencing.

By blood supply, the market is segmented into patient blood and donor blood. Patient blood supply analysis covers the qualitative detection of infectious diseases such as sexually transmitted diseases and blood-borne infections like sepsis, and blood grouping and typing analysis tests. Donor blood testing involves analysis of donor blood units, including infectious disease screening and blood grouping tests.

By end-user, the market is segmented into hospitals, standalone blood banks, and reference laboratories. By region, the blood screening and typing market is segmented into North America, Europe, the Asia-Pacific region and Rest of the World (ROW). ROW includes South America, the Middle East, and Africa. This report also covers the competitive landscape, detailing the companies engaged in offering products for blood screening and typing. Detailed profiles of the top leading companies are also included.

Companies Mentioned

  • Abbott Laboratories
  • Agena Bioscience
  • Axo Science
  • Bag Health Care Gmbh
  • Becton, Dickinson And Co.
  • Bio-Rad Laboratories
  • Biomérieux Sa
  • Danaher Corp.
  • Day Medical Sa
  • Diagast
  • F. Hoffmann-La Roche Ltd.
  • Grifols S.A.
  • Immucor
  • Novacyt Group
  • Ortho Clinical Diagnostics
  • Quotient
  • Siemens Healthcare Gmbh
  • Thermo Fisher Scientific, Inc.